Actinobacteria are one of the most important phyla of microorganisms that produce a wide variety of bioactive secondary metabolites, 1,2 including many clinically used antibiotics and anticancer drugs. 3,4 A contemporary strategy for obtaining new bioactive compounds is based on the isolation of rare actinomycetes from neglected environments, 5 which should contain gene clusters for biosynthetizing novel secondary metabolites. 6 One of the pharmaceutically and biotechnologically important rare actinomycetes that attracts natural products researchers is the genus Nocardiopsis. 7,8 Species of this genus are aerobic, Gram-positive, non-acid-fast, and their aerial mycelia bear long chains of spores. 9,10 Nocardiopsis species were mainly recovered from salty habitats. The members of this genus produce an array of bioactive compounds that may aid their survival under these conditions. 11 In recent years many new natural products, belonging to different classes of molecules, including polyketides and peptides, 12,13,14 were isolated from Nocardiopsis species. 15,16 These classes display cytotoxic, 17 antimicrobial, 18 and immunomodulatory activities. 19 Recently, three new angucyclines, nocardiopsistins A-C, with anti-Methicillin-Resistant Staphylococcus aureus (MRSA) activity were isolated from a marine sponge-derived Nocardiopsis sp. HB-J378, 20 and a new cytotoxic cyclic peptide was obtained from the marine sponge-associated Nocardiopsis sp. UR67. 14 According to the World Health Organization (WHO, 2018), «Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018 », hence it is necessary to continue the discovery of new classes of molecules with cytotoxic activity, which may be further developed as anticancer drugs. 14 In fact, cytotoxicity-guided fractionation of the crude extract of the marine obligate actinomycetes, Salinispora tropica, led to the isolation of salinosporamide A, which entered phase I human clinical trials for the treatment of multiple myeloma. 21 In the course of screening for new bioactive metabolites from our collection of actinobacteria, which had been isolated from different areas of Algeria, Nocardiopsis CG3